2631 - 2640 of 9033 Results
Title
Year
-
OPENTitle: Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 324Issue #: 8Start Page: 772End Page: 772Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2020.12134Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2768841/jama_palmqvist_2020_oi_200077_1597950344.77871.pdfCitation Count: 1476
-
OPENTitle: Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 5Start Page: 632End Page: 632Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2019.5154Best OA location URL: https://escholarship.org/uc/item/82s0j194Citation Count: 140
-
OPENTitle: Freezing of Gait and Its Levodopa ParadoxJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 287End Page: 287Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.4006Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2757501/jamaneurology_nonnekes_2019_vp_190017.pdfCitation Count: 62
- The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease2019RESTRICTEDTitle: The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 3Start Page: 295End Page: 295Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2019.3983Citation Count: 14
-
OPENTitle: Seven-Year Experience From the National Institute of Neurological Disorders and Stroke–Supported Network for Excellence in Neuroscience Clinical TrialsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 6Start Page: 755End Page: 755Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.0367Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7483960Citation Count: 9
-
OPENTitle: Thyroarytenoid Muscle Gene Expression in a Rat Model of Early‐Onset Parkinson's DiseaseJournal Name: The LaryngoscopePublisher: WileyVol: 131Issue #: 12Start Page: E2874End Page: E2879Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/lary.29661Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8595495Citation Count: 16
-
OPENTitle: The recent failure of the PROMESA clinical trial for multiple system atrophy raises the question—are polyphenols a viable therapeutic option against proteinopathies?Journal Name: Annals of Translational MedicinePublisher: AME Publishing CompanyVol: 8Issue #: 11Start Page: 719End Page: 719Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/atm.2020.01.117Best OA location URL: https://atm.amegroups.com/article/viewFile/35635/pdfCitation Count: 11
-
OPENTitle: Patient and caregiver characteristics associated with caregiver burden in Parkinson’s disease: a palliative care approachJournal Name: Annals of Palliative MedicinePublisher: AME Publishing CompanyVol: 9Issue #: S1Start Page: S24End Page: S33Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/apm.2019.10.01Best OA location URL: https://apm.amegroups.com/article/viewFile/31642/26522Citation Count: 165
- Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer2019RESTRICTEDTitle: Organoid Cultures as Preclinical Models of Non–Small Cell Lung CancerJournal Name: Clinical Cancer ResearchPublisher: American Association for Cancer Research (AACR)Vol: 26Issue #: 5Start Page: 1162End Page: 1174Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1158/1078-0432.ccr-19-1376Citation Count: 320
-
OPENTitle: Activation of the Akt1-CREB pathway promotes RNF146 expression to inhibit PARP1-mediated neuronal deathJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 663Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.aax7119Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7909008Citation Count: 44